Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 46 citing articles:

GABAA receptors as targets for treating affective and cognitive symptoms of depression
Bernhard Lüscher, Jamie Maguire, Uwe Rudolph, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 9, pp. 586-600
Open Access | Times Cited: 51
Modulators of GABAA receptor-mediated inhibition in the treatment of neuropsychiatric disorders: past, present, and future
Scott M. Thompson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 83-95
Closed Access | Times Cited: 30
Neurosteroids: mechanistic considerations and clinical prospects
Jamie Maguire, Steven Mennerick
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 73-82
Open Access | Times Cited: 26
Postpartum Depression: Etiology, Treatment, and Consequences for Maternal Care
Daiana Anne‐Marie Dimcea, Răzvan Petca, Mihai Cristian Dumitrașcu, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 865-865
Open Access | Times Cited: 12
The See-saw effect of Neuroactive Steroids and Endocrine Disrupting Compounds on Maternal Mental Health Status
S Aishwarya, V.M. Vinodhini, P. Renuka, et al.
NeuroToxicology (2025) Vol. 108, pp. 48-56
Closed Access | Times Cited: 1
Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
Doodipala Samba Reddy, Robert H. Mbilinyi, Emily R. Estes
Psychopharmacology (2023) Vol. 240, Iss. 9, pp. 1841-1863
Open Access | Times Cited: 20
Astrocytic GABAergic Regulation in Alcohol Use and Major Depressive Disorders
Dina Ali, H. Mokdad Ali, Matthew R. Lopez, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 318-318
Open Access | Times Cited: 7
Functional Food Nutrients, Redox Resilience Signaling and Neurosteroids for Brain Health
Maria Scuto, Miroslava Majzúnová, Gessica Torcitto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12155-12155
Open Access | Times Cited: 6
Efficacy, Tolerability, and Safety of Toludesvenlafaxine for the Treatment of Major Depressive Disorder—A Narrative Review
Octavian Vasiliu
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 411-411
Open Access | Times Cited: 13
Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review
Rafał Marecki, Joanna Kałuska, Agata Kolanek, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 13
Milestone review: GABA, from chemistry, conformations, ionotropic receptors, modulators, epilepsy, flavonoids, and stress to neuro‐nutraceuticals
Graham A.R. Johnston, Philip M. Beart
Journal of Neurochemistry (2024) Vol. 168, Iss. 7, pp. 1179-1192
Open Access | Times Cited: 5
Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression
Sara V. Carlini, Lauren M. Osborne, Kristina M. Deligiannidis
Dialogues in Clinical Neuroscience (2023) Vol. 25, Iss. 1, pp. 92-100
Open Access | Times Cited: 12
Postmarketing safety profile of brexanolone: a pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS)
Meilian Zhang, Wenhuo Xie, Jianbin Li, et al.
Archives of Women s Mental Health (2023) Vol. 27, Iss. 1, pp. 35-44
Closed Access | Times Cited: 11
Potential therapeutic effects of Chinese herbal medicine in postpartum depression: Mechanisms and future directions
Hongxiao Xie, Zhiqiang Xie, Fei Luan, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117785-117785
Closed Access | Times Cited: 4
Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Postpartum Depression and Child Mental Health Outcomes: Evidenced-Based Interventions
Eliza M. Wierzbinska, Leah C. Susser
Current Treatment Options in Psychiatry (2025) Vol. 12, Iss. 1
Closed Access
Neurosteroid influence on affective tone
Najah Walton, Pantelis Antonoudiou, Jamie Maguire
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105327-105327
Open Access | Times Cited: 9
The efficacy and safety of some new GABAkines for treatment of depression: A systematic review and meta-analysis from randomized controlled trials
Jiao Zou, Ling Yang, Guoyu Yang, et al.
Psychiatry Research (2023) Vol. 328, pp. 115450-115450
Closed Access | Times Cited: 9
Mid-pregnancy allopregnanolone levels and trajectories of perinatal depressive symptoms
Richelle D. Björväng, Ylva Walldén, Emma Fransson, et al.
Psychoneuroendocrinology (2024) Vol. 164, pp. 107009-107009
Open Access | Times Cited: 3
Neurosteroids and translocator protein 18 kDa (TSPO) ligands as novel treatment options in depression
Marco Riebel, Lisa-Marie Brunner, Caroline Nothdurfter, et al.
European Archives of Psychiatry and Clinical Neuroscience (2024)
Open Access | Times Cited: 3
Perinatal Depression: A Guide to Detection and Management in Primary Care
Manish Dama, Ryan J. Van Lieshout
The Journal of the American Board of Family Medicine (2023) Vol. 36, Iss. 6, pp. 1071-1086
Open Access | Times Cited: 8
A novel tool for risk assessment, screening, diagnosis, assessment, and therapy in postpartum depression
Prachi Sharma, Kanav Khera
International Journal of Gynecology & Obstetrics (2024) Vol. 166, Iss. 2, pp. 617-625
Closed Access | Times Cited: 2
The Role of Sleep Protection in Preventing and Treating Postpartum Depression
Nicole Leistikow, Milena H. Smith
Seminars in Perinatology (2024) Vol. 48, Iss. 6, pp. 151947-151947
Closed Access | Times Cited: 2
Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes
Simona Scheggi, Luca Concas, Sara Corsi, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105842-105842
Open Access | Times Cited: 2
Neurosteroids as positive and negative allosteric modulators of ligand-gated ion channels: P2X receptor perspective
Sonja Sivcev, Eva Kudová, Hana Zemková
Neuropharmacology (2023) Vol. 234, pp. 109542-109542
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top